Clinical Trial

Post-extubation Nasal Humidified High-flow Oxygen Versus Non-invasive Positive Pressure Ventilation

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2025 (before its estimated October 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Acute hypercapnic respiratory failure (AHRF), which is commonly defined as arterial partial pressure of carbon dioxide (PaCO2) ≥ 45 mmHg and frequently accompanied by reduced levels of arterial partial pressure of oxygen (PaO2), can occur in a variety of etiologies, mainly in chronic respiratory diseases, such as exacerbation of chronic obstructive pulmonary disease, cystic fibrosis, thoracic deformities, as well as other conditions, such as neuromuscular disease The purpose of this research is to To compare efficacy of administration of high flow nasal canula versus non-invasive mechanical ventilation on preventing reintubation during 72 hours postextubation of patients with type 2 respiratory failure with difficult weaning.
Trial Details
NCT Number NCT06918288
Lead Sponsor Benha University
Conditions Respiratory Failure With Hypercapnia
Enrollment 100 participants
Start Date 2025-03-01
Primary Completion 2025-10-01 (estimated)
Study Completion 2025-10-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-09